Vol 8, No 1 (February 01, 2019): Translational Lung Cancer Research (Stereotactic Body Radiation Therapy for Thoracic Malignancies)

Original Article

Predictors of pneumonitis-free survival following lung stereotactic body radiation therapy
Sibo Tian, Jeffrey M. Switchenko, Richard J. Cassidy, Chase E. Escott, Richard Castillo, Pretesh R. Patel, Walter J. Curran, Kristin A. Higgins

Review Article

Optimizing immobilization, margins, and imaging for lung stereotactic body radiation therapy
Jason K. Molitoris, Tejan Diwanji, James W. Snider III, Sina Mossahebi, Santanu Samanta, Nasarachi Onyeuku, Pranshu Mohindra, J. Isabelle Choi, Charles B. Simone II
Medically inoperable stage I non-small cell lung cancer: best practices and long-term outcomes
J. Isabelle Choi
The evolving toxicity profile of SBRT for lung cancer
Marcher Thompson, Kenneth E. Rosenzweig
Stereotactic body radiotherapy for centrally located stage I nonsmall cell lung cancer
Andrew Bang, Andrea Bezjak
Approaches to stereotactic body radiation therapy for large (≥5 centimeter) non-small cell lung cancer
Vivek Verma, Charles B. Simone II
Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapy
Michael T. Milano, Feng-Ming (Spring) Kong, Benjamin Movsas
The optimal treatment approaches for stage I small cell lung cancer
Amy C. Moreno, Steven H. Lin
Stereotactic ablative body radiation for oligometastatic and oligoprogressive disease
Matthew S. Ning, Daniel R. Gomez, John V. Heymach, Stephen G. Swisher
Combining stereotactic body radiation therapy with immunotherapy: current data and future directions
Alexander J. Lin, Michael Roach, Jeffrey Bradley, Clifford Robinson

Disclosure:

The focused issue “Stereotactic Body Radiation Therapy for Thoracic Malignancies” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. J. Isabelle Choi and Charles B. Simone II served as the unpaid Guest Editors for the focused issue.